TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Concord Medical Services ( (CCM) ) is now available.
On June 20, 2025, Concord Healthcare Group Co., Ltd., a subsidiary of Concord Medical Services, announced that its controlling shareholder, Beijing Concord Medical Technology Co., Ltd., sold 32,800,000 H shares of Concord Healthcare. This transaction, conducted at HK$6.12 per share, represents approximately 4.46% of the total issued shares, impacting the company’s shareholding structure.
Spark’s Take on CCM Stock
According to Spark, TipRanks’ AI Analyst, CCM is a Underperform.
The overall stock score for Concord Medical Services is significantly impacted by its poor financial performance, characterized by declining revenues, high leverage, and negative cash flows. Technical analysis indicates bearish momentum, and valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield. These factors collectively contribute to a low overall stock score, highlighting considerable risk.
To see Spark’s full report on CCM stock, click here.
More about Concord Medical Services
Concord Medical Services Holdings Limited operates in the healthcare industry, focusing on providing medical services and healthcare management. The company is involved in managing hospitals and clinics, and it has a market presence in China, with its subsidiary Concord Healthcare Group Co., Ltd. listed on the Hong Kong Stock Exchange.
Average Trading Volume: 33,185
Technical Sentiment Signal: Strong Sell
Current Market Cap: $25.51M
Find detailed analytics on CCM stock on TipRanks’ Stock Analysis page.